Pharmaceuticals, Biotechnology and Life Sciences
WALTHAM, Mass.–(BUSINESS WIRE)–Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and…
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq:PPD) today announced the cancellation of its fireside chat and related webcast at the Barclays Global…
LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive…
PARIS–(BUSINESS WIRE)–MedDay Pharmaceuticals announced today that the second pivotal Phase III trial (SPI2) of its investigational product MD1003 has not…
New investments from IP Group, Baylor College of Medicine (BCM) and Schroeder Adveq Proceeds to fund phase 1 studies in…
First demonstration of durable control of viremia without antiviral therapy in 9 of 13 SHIV-infected monkeys receiving combination therapy with…
BOSTON–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today presented longer-term results from the DISCOVER trial of Descovy (emtricitabine 200 mg and…
Accelerates clinical trial processes and time to market, while delivering “right-sized” solutions, at a fraction of the cost and time…
DUBLIN–(BUSINESS WIRE)–The “Biogen Inc (BIIB) – Financial and Strategic SWOT Analysis Review” swot analysis has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Regeneron Pharmaceuticals Inc (REGN) – Financial and Strategic SWOT Analysis Review” swot analysis has been added to ResearchAndMarkets.com’s…